Therapeutics

Eptastigmine

Tools

Back to the Top

Overview

Name: Eptastigmine
Synonyms: MF 201
Therapy Type: Small Molecule (timeline)
Target Type: Cholinergic System (timeline)
Condition(s): Alzheimer's Disease
U.S. FDA Status: Alzheimer's Disease (Discontinued)
Company: Mediolanum
Approved for: None

Background

Eptastigmine is a centrally acting cholinesterase inhibitor.

Last Updated: 16 Oct 2013

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

References

No Available References

Further Reading

No Available Further Reading